Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #731

    small new trial: FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia https://clinicaltrials.gov/ct2/show/NCT04714372 https://fatetherapeutics.com/pipeline/immuno-oncology-candidates/ft538/

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #732

      Genmab's neighbour Merus NV Announce Collaboration with Lilly to research and develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies. https://ir.merus.nl/news-releases/news-release-details/lilly-and-merus-nv-announce-collaboration-discover-novel-t-cell

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #733

        Ritzau: https://www.proinvestor.com/investornyt/671252/eli-lilly-indgar-nyt-udviklingssamarbejde-med-milliardpotentiale

        1 Reply Last reply
        0
        • Legolas23L Offline
          Legolas23L Offline
          Legolas23
          wrote on sidst redigeret af
          #734

          US gør det de skal..

          1 Reply Last reply
          0
          • Legolas23L Offline
            Legolas23L Offline
            Legolas23
            wrote on sidst redigeret af
            #735

            Det ligner der blev indsendt RTOR Amivantamab i starten af december, så mon ikke den tidligst kommer midt februar.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #736

              Hvor er du stødt på RTOR? Jeg har ikke kunnet finde noget om det.

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #737

                https://www.jnj.com/janssen-submits-application-to-u-s-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations
                Nej, der er vist ikke RTOR på Amivantamab. Det var en fejl fra min side. Her JNJs pm

                1 Reply Last reply
                0
                • Legolas23L Offline
                  Legolas23L Offline
                  Legolas23
                  wrote on sidst redigeret af
                  #738

                  Er der ikke søgt på et ph2 ?

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #739

                    Nej, på ph1 studie ved navn CHRYSALIS

                    1 Reply Last reply
                    0
                    • Legolas23L Offline
                      Legolas23L Offline
                      Legolas23
                      wrote on sidst redigeret af
                      #740

                      Troede ikke man kunne søge på ph1

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        mobbyduck1
                        wrote on sidst redigeret af
                        #741

                        hvad forventer vi den 26/1 mht Kesimpta?? Er der nogen ide om, hvor højt salget er
                        ??

                        1 Reply Last reply
                        0
                        • M Offline
                          M Offline
                          mobbyduck1
                          wrote on sidst redigeret af
                          #742

                          for q4

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #743

                            Er Novartis begyndt kræve betaling?

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #744

                              I think it will be a very small amount, since Novartis was giving Kesimpta away for free at the start:

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #745

                                27/10 12:57
                                af E L
                                To provide access to eligible US patients while they obtain reimbursement we are providing Kesimpta free of charge for a limited amount of time. Based on our assumption on the time from initiation of therapy to reimbursement we anticipate that a majority of the sales in the first quarter of launch will be free goods and have accrued accordingly. We expect this share to decrease over time as reimbursement progresses

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  mobbyduck1
                                  wrote on sidst redigeret af
                                  #746

                                  ok thx

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #747

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #748

                                      Onsdagens aviser med Joe Biden, hjemmearbejde og aktieboblehttps://www.proinvestor.com/investornyt/671262/onsdagens-aviser-med-joe-biden-hjemmearbejde-og-aktieboble

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #749

                                        Jep - jeg forventer at vi ser en stigning m/m på intet mindre end 20%

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          Hen
                                          wrote on sidst redigeret af
                                          #750

                                          Bank of America sänker sin rekommendation för Genmab till neutral från köp.
                                          Det rapporterar nyhetstjänsten PLX.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger